← Leaderboards
Melisa L Wong
University Of California, San Francisco
$2,163,960
Attributed
$2,163,960
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $658.7K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,163,960 · 3
By mechanism
K76$1,267,467 · 1
R37$658,743 · 1
R03$237,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Rebecca L Sudore$11,687,748
- Meredith Greene$1,446,725
- Payam Nahid$19,473,523
- Sheri Dawn Weiser$14,342,815
- Jennifer C. Lai$13,060,291
Others in their field
Other Emerging Leaders on “Quality Of Life”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Martha Hering · Westat, Inc.$57,098,843
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Abraham Aizer Brody · New York University School Of Medicine$40,849,810
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
- Greg Yothers · University Of Chicago$35,003,821
Research focus
Quality Of LifeChemotherapyMalignant NeoplasmsPhysical PerformanceCancer TherapyCharacteristicsHuman Old Age (65+)Malignant Neoplasm Of LungFunctional DeclinePatient OrientedGeriatric AssessmentHigh RiskOncologyOncologistAffectElderlyDecision MakingImmunotherapyAwardCohort StudiesCommunicationFunctional StatusComplexCancer Patient
Grant awards (9)
Predicting trajectories of function, cognition, and quality of life among older adults with advanced lung cancer$658,743
R37 · FY2025 · CA · contact PI
Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions$242,381
K76 · FY2023 · AG · contact PI
Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions$242,543
K76 · FY2022 · AG · contact PI
Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions$242,992
K76 · FY2021 · AG · contact PI
Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions$242,614
K76 · FY2020 · AG · contact PI
Administrative Supplement to Promote Research Continuity and Retention$53,999
K76 · FY2020 · AG · contact PI
Advancing patient-centered decision making in older adults with lung cancer: Incorporating risk of functional decline into treatment discussions$242,938
K76 · FY2019 · AG · contact PI
Expanding the Definition of Treatment Toxicity in Older Adults with Lung Cancer$118,875
R03 · FY2018 · AG · contact PI
Expanding the Definition of Treatment Toxicity in Older Adults with Lung Cancer$118,875
R03 · FY2017 · AG · contact PI